Refine by
Inflammatory Process Suppliers In Singapore
1 companies found
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-300-IV is being developed for the treatment of diabetic complications, including diabetic kidney disease known as diabetic ...